AMGN · News · 20260911N
Free Cash Flow
AMGEN INC · 2026-09-11 · Importance 38 · Surprise 6 · In source text
Amgen generated more than $8.1 billion in free cash flow during its latest fiscal year. The reported cash generation was cited as evidence of Amgen’s financial stability relative to clinical-stage biotechnology companies. The cash-flow profile supports Amgen’s established commercial platform and dividend-paying capacity.
Key facts
- Amgen generated over $8.1 billion in free cash flow during its latest fiscal year. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | realized | — | Amgen generated over $8.1 billion in free cash flow during its latest fiscal year. |